Related Experiment Video
Updated: Jun 29, 2026

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
Dopa-responsive dystonia (Segawa syndrome).
Neel Kamal1, Deepti Pagare Bhat, Emma Carrick
1Childrens Center, Hull and East Riding Community Health NHS Trust, Hull, United Kingdom. neel.kamal@humber.nhs.uk
Segawa syndrome, a rare neurological disorder, was diagnosed in a boy with developmental delay initially thought to be cerebral palsy. Low-dose L-Dopa therapy led to significant clinical improvement, highlighting the importance of accurate diagnosis.
Area of Science:
- Neurology
- Genetics
- Pediatrics
Background:
- Global developmental delay is a significant concern in pediatric neurology.
- Cerebral palsy is a common diagnosis for motor impairments in children.
- Accurate diagnosis is crucial for effective treatment of neurodevelopmental disorders.
Observation:
- A 12-year-old boy presented with progressive global developmental delay.
- Initial diagnosis was quadriplegic cerebral palsy, but marked dystonia suggested an alternative.
- The patient exhibited features suspicious of Segawa syndrome (dopa-responsive dystonia).
Findings:
- Genetic testing or further clinical evaluation confirmed Segawa syndrome.
- Treatment with a low dose of Levodopa (L-Dopa) resulted in dramatic clinical improvement.
- This case underscores the dopa-responsiveness characteristic of Segawa syndrome.
Implications:
- Misdiagnosis of cerebral palsy can delay appropriate treatment for treatable conditions like Segawa syndrome.
- Early identification and management of Segawa syndrome can significantly improve patient outcomes.
- This highlights the importance of considering treatable genetic conditions in pediatric developmental delay and movement disorders.
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Parkinson Disease ll: Pathophysiology
Alterations in Muscle Tone ll
Alterations in Muscle Tone lll

